Summary: Recursion is leveraging AI and machine learning to decode biology and radically improve lives through drug discovery and development. With one of the largest biological and chemical datasets, Recursion combines experimental science with AI to discover new drugs at scale, targeting a wide range of diseases including oncology and rare genetic disorders.

Summary: Medidata AI leverages the power of machine learning and artificial intelligence to transform clinical trials. With data from over 36,000 clinical trials and insights from 11 million patients, Medidata AI offers predictive modeling, operational optimization, and evidence generation to streamline trial protocols, enhance data management, and support faster, smarter clinical trials.

Summary: Oncora Medical provides oncology-specific artificial intelligence solutions designed to enhance clinical workflows and deliver cutting-edge technology. Their offerings include Registry AI for transforming cancer registries, Clinical AI as an oncology-specific AI scribe for documentation, and Research AI to support oncology research efforts. These tools empower cancer registry professionals and oncology clinical care team members with intelligent quality control and data management capabilities.

Summary: Trialbee Honey Platform™ revolutionizes patient recruitment by centralizing all referrals into a single funnel, offering data standardization across vendors, and providing visual ROI metrics for every partner. It delivers actionable insights for sites and candidates, streamlining the recruitment process and enhancing efficiency in clinical trials.

Summary: BenevolentAI leverages advanced AI and machine learning technologies to transform the landscape of life science research and development. By harnessing a unique knowledge graph and proprietary ontologies, the platform empowers scientists and executives to make complex decisions with confidence and precision, driving groundbreaking discoveries in the field.

Summary: Atomwise utilizes an AI engine to revolutionize the drug discovery process, focusing on the development of new small molecule medicines. By leveraging machine learning and convolutional neural networks, Atomwise aims to accelerate the identification and development of new drugs, addressing some of the most challenging problems in medicine today.

Summary: Curebase offers a comprehensive platform designed to launch studies faster, improve data quality, and enhance patient engagement. It integrates tools for ePRO, eConsent, scheduling, notifications, and EDC, aiming to streamline the clinical trial process for researchers and participants alike. The platform is trusted by leading life sciences teams to power their clinical trials with its modern, intuitive interface and robust data management capabilities.

Summary: ConcertAI leverages advanced AI and real-world data (RWD) to accelerate translational medicine, clinical trials, clinical development, imaging & diagnostics, commercial insights, and oncology care. Their suite of products and solutions, including Precision Suite, TeraRecon, and CancerLinQ, provides comprehensive data and AI-driven insights to improve patient outcomes and drive brand success.

Summary: Aiforia equips pathologists and scientists with powerful deep learning AI and cloud-based technology to increase the speed, accuracy, and consistency of analyzing large and complex medical images in clinical, pre-clinical, and academic labs. Aiforia's mission is to transform pathology image analysis with AI, enabling better care for each patient through enhanced diagnostic precision and efficiency.

Summary: The Unlearn Platform utilizes artificial intelligence to generate digital twins of patients in clinical studies, offering predictions on every clinical outcome at future time points with unparalleled precision. This innovative approach aims to minimize trial failure, reduce costs, and accelerate timelines by enhancing trial efficiency, improving decision-making, and de-risking trial design.

Summary: Pharma.ai is a comprehensive suite of AI-driven tools and platforms designed by Insilico Medicine to enhance the quality and efficiency of pharmaceutical research. It leverages advanced AI technologies to automate and improve various aspects of drug discovery and development, from target identification through Generative Biologics to chemical synthesis with Chemistry42.

Summary: PharmAI's DiscoveryEngine leverages advanced AI and deep learning techniques to optimize high-throughput screening compound libraries, identify off-target effects early in the drug discovery process, and explore new chemical scaffolds. By utilizing a knowledge-based approach and analyzing the geometry of protein binding sites, the platform aims to accelerate the drug discovery process with high precision and efficiency.

Summary: Elicit is designed to streamline the research process by automating systematic reviews, data extraction, and the synthesis of findings from academic papers. It significantly reduces the time required for evidence synthesis, enabling researchers to analyze more evidence accurately and efficiently. With access to over 125 million academic papers, Elicit supports a wide range of research activities, from generating rapid systematic reviews to extracting data from hundreds of papers within minutes.

Summary: The Inovalon ONE® Platform integrates national-scale connectivity, real-time primary source data access, and advanced analytics to power over 100 cloud-based solutions. It is designed to improve clinical outcomes and healthcare economics across the healthcare ecosystem, supporting payers, providers, pharmacies, and life sciences organizations.

Summary: IQVIA Connected Intelligence™ brings together the right data, expertise, AI, analytics, and technology to address unique needs in the healthcare industry. It focuses on discovering new possibilities for success by making intelligent connections between customer needs, IQVIA's capabilities, and the broader healthcare ecosystem. This approach aims to help customers be more agile, accelerate results, and improve patient outcomes.

Summary: Cytel is at the forefront of improving the efficiency and success rates of the drug development process through its advanced statistical methodologies and software solutions. Specializing in adaptive trial designs, biometrics, and real-world evidence analysis, Cytel supports life sciences companies in making informed decisions at every stage of clinical research, aiming to shorten development cycles and enhance patient outcomes.

Summary: SOPHiA DDM™ is at the forefront of democratizing data-driven medicine by providing clinicians with AI-driven insights across oncology and inherited disorders. The platform streamlines workflows, expedites results, and fosters precision medicine expertise, ensuring data privacy and security. It supports healthcare professionals and BioPharma companies throughout the drug development continuum, optimizing clinical trial development and market access strategies.

Summary: Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. With one of the world's largest libraries of clinical and molecular data, Tempus enables physicians to make real-time, data-driven decisions to deliver personalized patient care and in parallel, facilitates discovery, development, and delivery of optimal therapeutics. The platform's key features include genomic profiling, algorithmic tests, and clinical trial matching among others.

Summary: PALLUX leverages AI to analyze patient records against clinical guidelines, identifying untreated and under-treated patients. It focuses on a wide range of conditions from common diseases like COPD and CKD to rare conditions like Cancer Cachexia and Lupus Nephritis. The platform aims to improve clinical outcomes by ensuring patients receive timely diagnoses and treatments.

Summary: Skan AI offers a comprehensive solution for healthcare payers to address high claims processing costs, payment accuracy, and member satisfaction. By providing insights into claims processes, Skan AI enables payers to identify and fix bottlenecks, reduce manual compliance checks, and automate costly manual tasks, leading to significant cost savings and operational efficiency.